Expression of functional recombinant mosquito salivary apyrase: A potential therapeutic platelet aggregation inhibitor

Platelets

Volumn 17, Issue 3, 2006, Pages 178-184

  Sun, Dongfeng ^a   Mcnicol, Archibald ^a   James, Anthony A ^b   Peng, Zhikang ^a  

^a UNIVERSITY OF MANITOBA   (Canada)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Adenosine diphosphate; Aedes aegypti; Baculovirus insect cell expression system; Mosquito; Platelet aggregation inhibitor; Recombinant apyrase

Indexed keywords

ADENOSINE DIPHOSPHATE; ADENOSINE TRIPHOSPHATE; ANTITHROMBOCYTIC AGENT; NUCLEOTIDASE; RECOMBINANT APYRASE; RECOMBINANT ENZYME; UNCLASSIFIED DRUG;

ANIMAL CELL; ANION EXCHANGE CHROMATOGRAPHY; ARTICLE; BACULOVIRUS EXPRESSION SYSTEM; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG MECHANISM; DRUG PURIFICATION; ENZYME ACTIVITY; ENZYME PURIFICATION; HUMAN; HUMAN CELL; INSECT CELL; MOLECULAR WEIGHT; MOSQUITO; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; THROMBOCYTE AGGREGATION; THROMBOCYTE AGGREGATION INHIBITION; THROMBOCYTE FUNCTION; THROMBOSIS; WHOLE CELL;

AEDES; ANIMALS; APYRASE; BACULOVIRIDAE; GENE EXPRESSION; GENETIC VECTORS; HUMANS; PLATELET AGGREGATION; PLATELET AGGREGATION INHIBITORS; PYRIDINES; RECEPTORS, PURINERGIC P2; RECOMBINANT PROTEINS; SALIVARY PROTEINS;

AEDES AEGYPTI; ANIMALIA; INSECTA;

EID: 33646950787     PISSN: 09537104     EISSN: 13691635     Source Type: Journal    
DOI: 10.1080/09537100500460234     Document Type: Article

References (39)

1. Ruggeri ZM. Mechanisms initiating platelet thrombus formation. Thromb Haemost 1997;78:611-616.
2. Ni H, Freedman J. Platelets in hemostasis and thrombosis: Role of integrins and their ligands. Transfus Apheresis Sci 2003;28:257-264.
3. Ni H, Denis CV, Subbarao S, Degen JL, Sato TN, Hynes RO, Wagner DD. Persistence of platelet thrombus formation in arterioles of mice lacking both von Willebrand factor and fibrinogen. J Clin Invest 2000;106:385-392.
4. Chen H, Locke D, Liu Y, Liu C, Kahn ML. The platelet receptor GPVI mediates both adhesion and signaling responses to collagen in a receptor density-dependent fashion. J Biol Chem 2002;277:3011-3019.
5. Robson SC, Kaczmarek E, Siegel JB, Candinas D, Koziak K, Millan M, Hancock WW, Bach FH. Loss of ATP diphosphohydrolase activity with endothelial cell activation. J Exp Med 1997;185:153-163.
6. Marcus AJ, Broekman MJ, Drosopoulos JH, Islam N, Alyonycheva TN, Safier LB, Hajjar KA, Posnett DN, Schoenborn MA, Schooley KA, Gayle RB, Maliszewski CR. The endothelial cell ecto-ADPase responsible for inhibition of platelet function is CD39. J Clin Invest 1997;99:1351-1360.
7. Kaczmarek E, Koziak K, Sevigny J, Siegel JB, Anrather J, Beaudoin AR, Bach FH, Robson SC. Identification and characterization of CD39/vascular ATP diphosphohydrolase. J Biol Chem 1996;271:33116-33122.
8. Vachereau A, Ribeiro JMC. Immunoreactivity of salivary gland apyrase of Aedes aegypti with antibodies against a similar hydrolase present in the pancreas of mammals. Insect Biochem 1989;19:527-534.
9. Champagne DE, Smartt CT, Ribeiro JM, James AA. The salivary gland-specific apyrase of the mosquito Aedes aegypti is a member of the 5′-nucleotidase family. Proc Natl Acad Sci USA 1995;92:694-698.
10. Smartt CT, Kim AP, Grossman GL, James AA. The Apyrase gene of the vector mosquito, Aedes aegypti, is expressed specifically in the adult female salivary glands. Exp Parasitol 1995;81:239-248.
11. Schmidt M, McConnell TJ, Hoffman DR. Production of a recombinant imported fire ant venom allergen, Sol i 2, in native and immunoreactive form. J Allergy Clin Immunol 1996;98:82-88.
12. Ueshima S, Holvoet P, Lijnen HR, Nelles L, Seghers V, Collen D. Expression and characterization of clustered charge-to-alanine mutants of low M(r) single-chain urokinase-type plasminogen activator. Thromb Haemost 1994;71:134-140.
13. Sui LM, Wong C, Petra PH. Over-expression of human sex steroid-binding protein (hSBP/hABP or hSHBG) in insect cells infected with a recombinant baculovirus. Characterization of the recombinant protein and comparison to the plasma protein. J Steroid Biochem Mol Biol 1995;52:173-179.
14. O'Reilly DR, Miller LK, Luckow VA, Baculovirus Expression vectors: A laboratory manual. London: Oxford University Press; 1994.
15. Matsuura Y, Possee RD, Overton HA, Bishop DH. Baculovirus expression vectors: The requirements for high level expression of proteins, including glycoproteins. J Gen Virol 1987;68:1233-1250.
16. Faudry E, Lozzi SP, Santana JM, D'Souza-Ault M, Kieffer S, Felix CR, Ricart CA, Sousa MV, Vernet T, Teixeira AR. Triatoma infestans apyrases belong to the 5′-nucleotidase family. J Biol Chem 2004;279:19607-19613.
17. Marcus AJ, Broekman MJ, Drosopoulos JH, Islam N, Pinsky DJ, Sesti C, Levi R. Metabolic control of excessive extracellular nucleotide accumulation by CD39/ectonucleotidase-1: Implications for ischemic vascular diseases. J Pharmacol Exp Ther 2003;305:9-16.
18. Peng Z, Xu W, James AA, Lam H, Sun D, Cheng L, Simons FER. Expression, purification, characterization, and clinical relevance of rAed a 1 - a 68 kDa recombinant mosquito Aedes aegypti salivary allergen. Inter Immunol 2001;13:1445-1452.
19. Baykov AA, Evtushenko OA, Avaeva SM. A malachite green procedure for orthophosphate determination and its use in alkaline phosphatase-based enzyme immunoassay. Anal Biochem 1988;171:266-270.
20. Picher M, Sevigny J, D'Orleans-Juste P, Beaudoin AR. Hydrolysis of P2-purinoceptor agonists by a purified ectonucleotidase from the bovine aorta, the ATP-diphosphohydrolase. Biochem Pharmacol 1996;51:1453-1460.
21. Handin RI. Platelets and coronary artery disease. New Engl J Med 1996;334:1126-1127.
22. Ruggeri ZM. Platelets in atherothrombosis. Nat Med 2002;8:1227-1234.
23. Clutton P, Folts JD, Freedman JE. Pharmacological control of platelet function. Pharmacol Res 2001;44:255-264.
24. Bennett JS. Novel platelet inhibitors. Annu Rev Med 2001;52:161-184.
25. McNicol A, Israels SJ. Platelets and anti-platelet therapy. J Pharmacol Sci 2003;93:381-396.
26. Casserly IP, Topol EJ. Glycoprotein IIb/IIIa antagonists - From bench to practice. Cell Mol Life Sci 2002;59:478-500.
27. Chew DP, Bhatt DL, Topol EJ. Oral glycoprotein IIb/IIIa inhibitors: Why don't they work? Am J Cardiovasc Drugs 2001;1:421-428.
28. Collaboration AT. Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. Br Med J 2002;324:71-86.
29. Eikelboom JW, Hirsh J, Weitz JI, Johnston M, Yi Q, Yusuf S. Aspirin-resistant thromboxane biosynthesis and the risk of myocardial infarction, stroke, or cardiovascular death in patients at high risk for cardiovascular events. Circulation 2002;105:1650-1655.
30. Kam PC, Nethery CM. The thienopyridine derivatives (platelet adenosine diphosphate receptor antagonists), pharmacology and clinical developments. Anaesthesia 2003;58:28-35.
31. Cannon CP. Effectiveness of clopidogrel versus aspirin in preventing acute myocardial infarction in patients with symptomatic atherothrombosis (CAPRIE trial). Am J Cardiol 2002;90:760-762.
32. Handa M, Guidotti G. Purification and cloning of a soluble ATP-diphosphohydrolase (apyrase) from potato tubers (Solanum tuberosum). Biochem Biophys Res Commun 1996;218:916-923.
33. Ribeiro JM, Endris TM, Endris R. Saliva of the soft tick, Ornithodoros moubata, contains anti-platelet and apyrase activities. Comp Biochem Physiol A 1991;100:109-112.
34. Champagne DE. Antihemostatic strategies of blood-feeding arthropods. Curr Drug Targets Cardiovasc Haematol Disord 2004;4:375-396.
35. Mans BJ, Gasper AR, Louw AI, Neitz AW. Purification and characterization of apyrase from the tick, Ornithodoros savignyi. Comp Biochem Physiol B Biochem Mol Biol 1998;120:617-624.
36. Ribeiro JM, Valenzuela JG. The salivary purine nucleosidase of the mosquito, Aedes aegypti. Insect Biochem Mol Biol 2003;33:13-22.
37. Ribeiro J. Role of arthropod saliva in blood feeding. Ann Rev Entomol 1987;32:463-478.
38. Gayle RB, 3rd, Maliszewski CR, Gimpel SD, Schoenborn MA, Caspary RG, Richards C, Brasel K, Price V, Drosopoulos JH, Islam N, Alyonycheva TN, Broekman MJ, Marcus AJ. Inhibition of platelet function by recombinant soluble ecto-ADPase/CD39. J Clin Invest 1998;101:1851-1859.
39. Dai J, Liu J, Deng Y, Smith TM, Lu M. Structure and protein design of a human platelet function inhibitor. Cell 2004;116:649-659.